AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

AptarGroup Inc.

In a report released today, Adam Seiden from Barclays assigned a Hold rating to Caterpillar, with a price target of $800.00. Seiden covers the Indu...

Barclays Gives a Hold Rating to Caterpillar (CAT)

Yamato Holdings Co ( ($JP:9064) ) just unveiled an update. Yamato Holdings has created a new Corporate Value Enhancement Committee to support susta...

Yamato Holdings Sets Up Corporate Value Enhancement Committee to Bolster Governance

Truist Financial analyst Jamie Cook maintained a Buy rating on Caterpillar yesterday and set a price target of $1,218.00. According to TipRanks, Co...

Truist Financial Reaffirms Their Buy Rating on Caterpillar (CAT)

An announcement from Astron Limited ( ($AU:ATR) ) is now available. Astron Limited has announced the appointment of Marcelo Bastos as a director ef...

Astron appoints new director Marcelo Bastos with no initial shareholding

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Definium Therapeutics (DFTX), Atricure (ATRC) and Pr...

Analysts Are Bullish on Top Healthcare Stocks: Definium Therapeutics (DFTX), Atricure (ATRC)

Bernstein analyst Chad Dillard maintained a Buy rating on Caterpillar today and set a price target of $879.00. Dillard covers the Industrials secto...

Bernstein Sticks to Their Buy Rating for Caterpillar (CAT)

RBC Capital analyst Sabahat Khan maintained a Buy rating on AtkinsRealis on June 22 and set a price target of C$120.00. The company’s shares closed...

RBC Capital Remains a Buy on AtkinsRealis (SNCAF)

Atrys Health SA ( ($ES:ATRY) ) has provided an update. Atrys Health disclosed the results of its Ordinary General Shareholders’ Meeting held on 18 ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ATR	$129.10	+0.15%	52.70K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ATR	$129.10	+0.1%	52.70K
3
4
5
6

ATR

ATR

Get AptarGroup Inc. Data in Excel

Get AptarGroup Inc. Data in Excel